Discover
SNDX
Syndax Pharmaceuticals, Inc.
20.23
1 x 20.21
3 x 20.24
bid
ask
-
0.14
0.69%
01:34 PM
timesize
| Ytd | -3.71% | |
| 1y | 61.71% |
19.95
day range
20.59
12.62
52 week range
25.59
| Open | 20.48 | Prev Close | 20.37 | Low | 19.95 | High | 20.59 | Mkt Cap | 1.79B |
| Vol | 498.26K | Avg Vol | 1.84M | EPS | -2.51 | P/E | -8.06 | Forward P/E | -37.16 |
| Beta | 0.40 | Short Ratio | 8.86 | Inst. Own | 120.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 20.41 | 200-d Avg | 20.50 | 1yr Est | 38.27 |
| Income Statement | |||
| Total Revenue | 72.79M | ||
| Revenues (USD) | 72.79M | ||
| Cost of Revenue | 3.21M | ||
| Gross Profit | 69.58M | ||
| Operating Expenses | 109.58M | ||
| Research and Development Expense | 68.04M | ||
| Selling, General and Administrative Expense | 41.54M | ||
| Operating Income | -39.99M | ||
| Interest Expense | 12.68M | ||
| Net Income | -49.36M | ||
| Net Income Common Stock | -49.36M | ||
| Net Income Common Stock (USD) | -49.36M | ||
| Consolidated Income | -49.36M | ||
| Earnings per Basic Share | -0.55 | ||
| Earnings per Basic Share (USD) | -0.55 | ||
| Earnings per Diluted Share | -0.55 | ||
| Earning Before Interest & Taxes (EBIT) | -36.69M | ||
| Earning Before Interest & Taxes (USD) | -36.69M | ||
| Weighted Average Shares | 88.99M | ||
| Weighted Average Shares Diluted | 88.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 336.58M | ||
| Cash and Equivalents (USD) | 336.58M | ||
| Investments | 245.01M | ||
| Investments Current | 217.79M | ||
| Investments Non-Current | 27.22M | ||
| Trade and Non-Trade Receivables | 70.13M | ||
| Current Assets | 675.04M | ||
| Property, Plant & Equipment Net | 1.29M | ||
| Total Assets | 703.65M | ||
| Debt Current | 506.00K | ||
| Total Debt | 589.38M | ||
| Current Liabilities | 99.68M | ||
| Debt Non-Current | 588.88M | ||
| Total Liabilities | 688.55M | ||
| Accumulated Retained Earnings (Deficit) | -1.60B | ||
| Accumulated Other Comprehensive Income | -140.00K | ||
| Shareholders Equity | 15.10M | ||
| Shareholders Equity (USD) | 15.10M | ||
| Assets Non-Current | 28.61M | ||
| Total Debt (USD) | 589.38M | ||
| Inventory | 33.16M | ||
| Liabilities Non-Current | 588.88M | ||
| Trade and Non-Trade Payables | 4.87M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 135.00K | ||
| Net Cash Flow from Financing | 252.77M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 205.58M | ||
| Capital Expenditure | -40.00K | ||
| Issuance (Purchase) of Equity Shares | 8.92M | ||
| Issuance (Repayment) of Debt Securities | 250.00M | ||
| Net Cash Flow from Investing | -16.91M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -16.87M | ||
| Net Cash Flow from Operations | -30.27M | ||
| Share Based Compensation | 14.01M | ||